Management & Regulatory

CordenPharma Expands Sterile Injectable Capacity in Italy
Management & Regulatory CordenPharma Expands Sterile Injectable Capacity in Italy

CordenPharma is proactively responding to the evolving healthcare landscape by enhancing its capabilities in assembling auto-injectors and other complex drug delivery formats for chronic disease management. As the global pharmaceutical market shifts towards self-administered therapies, the demand

Namibia Unveils First Public MRI to Boost Healthcare Equity
Management & Regulatory Namibia Unveils First Public MRI to Boost Healthcare Equity

The high cost of referring more than 4,000 state patients to private facilities for imaging services has historically drained approximately 16 million Namibian dollars from the public budget every year. This financial burden often meant that essential funds were diverted from other critical areas,

Pharma Industry Adapts to Climate Risks for Business Resilience
Management & Regulatory Pharma Industry Adapts to Climate Risks for Business Resilience

The intricate supply chains required to produce life-saving medications now face unprecedented risks from extreme weather events and critical resource scarcity. The global pharmaceutical sector is currently undergoing a fundamental transformation as climate change shifts from a corporate social

Mexico Mandates Nationwide Digital Health Integration by 2026
Management & Regulatory Mexico Mandates Nationwide Digital Health Integration by 2026

The success of the 2026 mandate hinges on the ability of rural clinics to access the same high-quality digital history as specialized private hospitals in Mexico City. By fundamentally altering the General Health Law, the federal government has declared digital health a matter of absolute public

How Is Bioprocessing Shaping the Future of Manufacturing?
Management & Regulatory How Is Bioprocessing Shaping the Future of Manufacturing?

Modern industrial sectors are witnessing a quiet revolution where microscopic organisms are replacing heavy machinery and toxic solvents in the race for cleaner and more efficient production. Industrial bioprocessing allows for the creation of complex medicines derived from living organisms,

Continuous Bioprocessing Market Set to Reach $1 Billion by 2030
Management & Regulatory Continuous Bioprocessing Market Set to Reach $1 Billion by 2030

Personalized medicine is emerging as a primary catalyst for manufacturing innovation, requiring flexible platforms that can efficiently produce high-yield therapies for smaller patient populations. This fundamental shift marks the end of the traditional era where massive, stainless-steel vats

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later